BioWorld - Tuesday, March 24, 2026

BioWorld Science

Oct. 11, 2021

View Archived Issues

New clotting cofactor-binding anticoagulant RNA aptamers presented

Read More

Enanta Pharmaceuticals synthesizes new anti-HBV compounds

Read More

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent AKT1/AKT2/AKT3 inhibitors

Read More

New GABA(A) receptor agonists described by Sumitomo Dainippon Pharma

Read More

New antibacterials discovered at Merck & Co.

Read More

Yangtze River Pharmaceutical, Shanghai Haiyan Pharmaceutical patent A2A/A2B receptor antagonists

Read More

New HIF-2alpha inhibitors discovered at Arcus Biosciences

Read More

DPX-SurMAGE dual T-cell therapy targeting MAGE-A9 and survivin shows promise in animal studies

Read More

Presepsin levels may be associated with COVID-19 mortality

Read More

Pharmacogenetic study identifies FKBP5 gene variants linked to treatment-resistant depression

Read More

SBIR grant supports POP Biotechnologies' development of theramostable vaccine for COVID-19

Read More

Mirati Therapeutics describes discovery and activity of GTPase KRAS inhibitor MRTX-1133

Read More

Recombinant AAVs for targeted gene delivery to muscle identified by a directed evolution approach

Read More

Filling the glass by emptying cancer cells' plates

Read More

Glycogen phosphorylase identified as a therapeutic target for anaplastic thyroid cancer

Read More